• Published in Lung Cancer Journal – 2022

  • Collaborator: Amgen

  • Authors: Amanda Tufman, Kathy Redmond, Andromachi Giannopoulou, Sebastian GonzalezMcQuire, Pasquale Varriale, Lena Geltenbort-Rost, Katarina Öhrling, Matthias Scheffler

To understand European non-small cell lung cancer (NSCLC) patients’ perceptions of disease burden, treatment, and future expectations of treatment and care. A 32-item online survey was conducted on a sample of NSCLC patients across Europe. Descriptive statistics were used to analyze the data. Results were presented by disease stage (I–III vs. IV).